The Efficacy of Epidermal Growth Factor Receptor–Specific Antibodies against Glioma Xenografts Is Influenced by Receptor Levels, Activation Status, and Heterodimerization
Terrance G. Johns(The Kids Research Institute Australia), Frank B. Furnari(University of California San Diego)
Cited by 84
Related Papers
Malignant astrocytic glioma: genetics, biology, and paths to treatment
|Genes & Development|2007|2.3k
Heterogeneity Maintenance in Glioblastoma: A Social Network
|Cancer Research|2011|435
The epidermal growth factor receptor variant <scp>III</scp> (<scp>EGFR</scp>v<scp>III</scp>): where wild things are altered
|FEBS Journal|2013|357
PTEN regulates glioblastoma oncogenesis through chromatin-associated complexes of DAXX and histone H3.3
|Nature Communications|2017|147